BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29526750)

  • 1. The ghrelin paradox in the control of equine chondrocyte function: The good and the bad.
    Ceriotti S; Consiglio AL; Casati L; Cremonesi F; Sibilia V; Ferrucci F
    Peptides; 2018 May; 103():1-9. PubMed ID: 29526750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
    Mosa R; Huang L; Li H; Grist M; LeRoith D; Chen C
    Am J Physiol Regul Integr Comp Physiol; 2018 Jan; 314(1):R71-R83. PubMed ID: 28903914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated and unacylated ghrelin protect MC3T3-E1 cells against tert-butyl hydroperoxide-induced oxidative injury: pharmacological characterization of ghrelin receptor and possible epigenetic involvement.
    Dieci E; Casati L; Pagani F; Celotti F; Sibilia V
    Amino Acids; 2014 Jul; 46(7):1715-25. PubMed ID: 24705647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food restriction, ghrelin, its antagonist and obestatin control expression of ghrelin and its receptor in chicken hypothalamus and ovary.
    Sirotkin AV; Pavlova S; Tena-Sempere M; Grossmann R; Jiménez MR; Rodriguez JM; Valenzuela F
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Jan; 164(1):141-53. PubMed ID: 22877785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the ghrelin receptor mediating its inhibitory action on inflammatory pain in rats.
    Sibilia V; Pagani F; Mrak E; Dieci E; Tulipano G; Ferrucci F
    Amino Acids; 2012 Oct; 43(4):1751-9. PubMed ID: 22407485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibitor and activator of ghrelin receptor (GHS-R1a) on porcine ovarian granulosa cell functions.
    Sirotkin AV; Meszarošová M; Grossmann R; Benčo A; Valenzuela F
    Gen Comp Endocrinol; 2011 Aug; 173(1):105-10. PubMed ID: 21600209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction.
    Yakabi K; Kurosawa S; Tamai M; Yuzurihara M; Nahata M; Ohno S; Ro S; Kato S; Aoyama T; Sakurada T; Takabayashi H; Hattori T
    Regul Pept; 2010 Apr; 161(1-3):97-105. PubMed ID: 20171995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.
    Esler WP; Rudolph J; Claus TH; Tang W; Barucci N; Brown SE; Bullock W; Daly M; Decarr L; Li Y; Milardo L; Molstad D; Zhu J; Gardell SJ; Livingston JN; Sweet LJ
    Endocrinology; 2007 Nov; 148(11):5175-85. PubMed ID: 17656463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular identification of ghrelin receptor (GHS-R1a) and its functional role in the gastrointestinal tract of the guinea-pig.
    Kitazawa T; Nakamura T; Saeki A; Teraoka H; Hiraga T; Kaiya H
    Peptides; 2011 Sep; 32(9):1876-86. PubMed ID: 21843569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat.
    Sibilia V; Muccioli G; Deghenghi R; Pagani F; De Luca V; Rapetti D; Locatelli V; Netti C
    J Neuroendocrinol; 2006 Feb; 18(2):122-8. PubMed ID: 16420281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple signaling pathways mediate ghrelin-induced proliferation of hippocampal neural stem cells.
    Chung H; Li E; Kim Y; Kim S; Park S
    J Endocrinol; 2013 Jul; 218(1):49-59. PubMed ID: 23608221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors.
    Muccioli G; Baragli A; Granata R; Papotti M; Ghigo E
    Neuroendocrinology; 2007; 86(3):147-64. PubMed ID: 17622734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a).
    Carreira MC; Camiña JP; Díaz-Rodríguez E; Alvear-Perez R; Llorens-Cortes C; Casanueva FF
    J Endocrinol; 2006 Oct; 191(1):147-57. PubMed ID: 17065398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of acylated ghrelin-specific receptor GHS-R1a antagonist in islet transplantation.
    Chinen K; Sakata N; Yoshimatsu G; Nakamura M; Kodama S
    Sci Rep; 2021 Oct; 11(1):21239. PubMed ID: 34711885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone secretagogue receptor (Ghs-R).
    Laviano A; Molfino A; Rianda S; Rossi Fanelli F
    Curr Pharm Des; 2012; 18(31):4749-54. PubMed ID: 22632856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin modulates lateral amygdala neuronal firing and blocks acquisition for conditioned taste aversion.
    Song L; Zhu Q; Liu T; Yu M; Xiao K; Kong Q; Zhao R; Li GD; Zhou Y
    PLoS One; 2013; 8(6):e65422. PubMed ID: 23762368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor.
    Muccioli G; Pons N; Ghè C; Catapano F; Granata R; Ghigo E
    Eur J Pharmacol; 2004 Sep; 498(1-3):27-35. PubMed ID: 15363972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two functional growth hormone secretagogue receptor (ghrelin receptor) type 1a and 2a in goldfish, Carassius auratus.
    Kaiya H; Miura T; Matsuda K; Miyazato M; Kangawa K
    Mol Cell Endocrinol; 2010 Oct; 327(1-2):25-39. PubMed ID: 20558240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary vasoconstrictor effect of ghrelin is not mediated by growth hormone secretagogue receptor 1a type in dogs.
    Sax B; Nadasy GL; Turi K; Hirschberg K; Furjesz D; Nagy A; Merkely B; Szabo G; Monos E; Kekesi V
    Peptides; 2011 Feb; 32(2):362-7. PubMed ID: 21126551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain and kidney GHS-R1a underexpression is associated with changes in renal function and hemodynamics during neurogenic hypertension.
    Sales da Silva E; Ferreira PM; Castro CH; Pacheco LF; Graziani D; Pontes CNR; Bessa ASM; Fernandes E; Naves LM; Ribeiro LCDS; Mendonça MM; Gomes RM; Pedrino GR; Ferreira RN; Xavier CH
    Mol Cell Endocrinol; 2020 Dec; 518():110984. PubMed ID: 32814069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.